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The possibility that the mutant mouse wasted (wst/wst) may serve as an animal model for studies of severe 
combined immunodeficiency disease (SCID) and the role of adenosine deaminase (ADA, EC 3.5.4.4) in 
adenosine metabolism were investigated. The specific activity of ADA in wst/wst compared with control 
mice was significantly lower by 26% in thymus, but significantly higher by 18% in spleen and 32% in cerebel- 
lum. l’,,, values of ADA in spleens were 43% higher in wst/wst mice and no changes were observed in K,,, 
values. In contrast, the V,, of ADA was unchanged in erythrocytes from wstlwst mice, but the K,,, for 
adenosine was significantly elevated. Thus, based on ADA measurements alone, it may be premature to 
consider wst/wst mice as a model for ADA deficiency and SCID in humans. 
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1. INTRODUCTION 
Adenosine deaminase (ADA, EC 3.5.4.4), a 
catabolic enzyme for adenosine and 2’-deoxy- 
adenosine, plays a potentially multifaceted role in 
regulating cellular levels of purines. One approach 
to the study of ADA is through the use of animals 
deficient in this enzyme. Recently, a genetic strain 
of mice designated wasted was described carrying 
an autosomal recessive trait which in homozygous 
(wstlwst) animals results in neurological abnor- 
malities, cerebellar degeneration [l], immunodefi- 
ciency, dramatically reduced tissue to body weight 
ratios for spleen, thymus and lymph nodes, and 
reduced numbers of lymphoid cells. While wst/wst 
mice were originally suggested as an animal model 
for ataxia telangiectasia [1,2], more recent work 
suggests closer similarities between the pathologi- 
cal changes in these mice and ADA-deficient 
humans suffering from severe combined immuno- 
deficiency disease @CID) [3]. On this basis and 
reported reductions of ADA activity in their 
erythrocytes [4], wst/wst mice were proposed as a 
possible animal model for KID. 
Our interest in ADA stems from the possibility 
that this enzyme may participate in regulating the 
neuromodulatory actions of adenosine in the CNS. 
In this regard, selective groups of parykarya and 
fiber systems immunoreactive for ADA have been 
identified in the rat and mouse brain [5-81. 
Moreover, ADA activity in discrete CNS regions 
corresponds closely with the pattern of neural 
elements immunoreactive for ADA [9]. To 
evaluate the utility of wasted mice for the study of 
CNS systems containing ADA, we investigated 
whether the reported deficiency of ADA in these 
mice is exhibited by CNS tissue and re-examined 
ADA activity in some peripheral tissues. 
2. MATERIALS AND METHODS 
2.1. Animals 
Heterozygote breeding pairs of C57 BL/6 x C3 
HeB/FeJ/Fl hybrid mice carrying the autosomal 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 431 
Volume 208, number 2 FEBS LETTERS November 1986 
recessive gene wasted (wst/wst) were obtained 
from the Jackson Laboratory (Bar Harbor, ME). 
Typically, the homozygous wst/wst animals ex- 
hibit progressive deterioration in health after 
weaning and die at approx. 30 days of age [2]. 
When wst/wst animals showed clear signs of 
wasting (23-27 days of age), the entire litter was 
killed by cervical fracture and whole brain, 
hypothalamus, cerebellum, thymus and spleens 
were dissected, frozen on dry ice and stored at 
- 80°C. Blood obtained by cardiac puncture using 
heparinized syringes was centrifuged at 3000 x g 
for 10 min and erythrocytes were stored at 
- 80°C. 
aqueous phase were chromatographed using 
reverse-phase HPLC [9]. ADA activity was ex- 
pressed as nmol product formed (inosine plus 
hypoxanthine)/mg protein per mg wet wt tissue or 
total activity per tissue. The K,,, and Vmax values 
were determined using computerized, weighted 
least-squares regression analysis. 
3. RESULTS 
2.2. ADA assay 
As described in [9], tissue samples were 
homogenized with a Polytron in ice-cold 50 mM 
Tris buffer, pH 7.0, containing 10 mM MgC12. 
50 ~1 aliquots of homogenate were added to reac- 
tion vessels containing concentrations of adenosine 
ranging from 7.8 to 500 ,uM. Following incubation 
at 37°C for 5-30 min, the reaction was stopped by 
adding 10 ,J of 20% trichloroacetic acid. The 
samples were neutralized and 25 yl aliquots of the 
The body weights of wst/wst mice, 7.7 -t 0.2 g, 
were significantly less than those of their littermate 
controls, 14.3 * 0.4 g (P < 0.001). In wst/wst 
mice, individual tissue weights, expressed as per- 
cent of control values, were 92070 for whole brain, 
29% for thymus, 27% for spleen and 91% for 
cerebellum. The weights of hypothalamus were un- 
changed. As shown in table 1, ADA activity (per 
mg tissue) in whole brain and cerebellum from 
wst/wst mice was 22 and 32% higher, respectively. 
These increases were also evident when the data 
were expressed as total tissue activity; higher by 
17% in brain and 26% in cerebellum. A non- 
significant increase of 11% was found in 
hypothalamus. In thymus and spleen of wst/wst 
Table 1 
Adenosine deaminase activity in tissues from control (C) and wasted (W) mice 
Tissue ADA activity (nmol/30 min) Tissue wt (g) 
Per mg 
protein 
Per mg 
tissue 
Total in 
tissue 
Whole brain (C) 86* 5 8 f 0.2 3265 f 129 415 f 10 (9) 
W) 108 k 15 10 * 1.1 3916 +- 4408 383 + 2a (4) 
Hypothalamus (C) 136 f 6 10 k 0.6 109 * 6 10 +_ 0.5 (15) 
(W) 139 +- 19 11 f 1.0 122 f 12 11 + 0.8 (7) 
Cerebellum (C) 81f 4 7 f 0.4 405 f 28 58 f 1 (10) 
(W) 117 f 4’ 10 f o.4c 548 f 34b 53 f la (7) 
Thymus (C) 3103 +_ 99 475 f 18 37467 f 2303 76 f 4 (15) 
(W) 2891 r 187 377 k 28b 6016 f 824’ 22 + 6’ (6) 
Spleen (C) 1221 + 56 170 + 10 9183 f 672 60 f 6 (11) 
(W) 1699 f 64’ 207 f 12a 3226 f 400’ 16 f 2’ (6) 
a p < 0.05 
bp < 0.01 
‘p<0.001 
Values represent means + SE of the number of determinations indicated in 
parentheses. Statistical analyses were conducted using a 2-tailed Student’s f-test 
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mice, the ADA activity (per mg tissue) was reduced 
by 26% in thymus, but increased by 18% in spleen. 
Similar patterns were observed when ADA activity 
was expressed as product formed/mg protein. A 
slightly different picture emerged when the data 
2 18 32 84 
I l/ADENOSINE (pMh103 
Fig. 1. Double-reciprocal plot of ADA activity in whole 
spleen homogenates v adenosine concentration from 
control (0) and wst/wst (0) mice. Symbols represent 
means f SE of three separate xperiments. Regression 
lines were drawn according to weighted least-squares 
analyses. Vmax (nmol/mg protein per 30 min) and K,,, 
GM) values for controls were 1329 f 51 and 23.7 f 2.8, 
and for wst/wst mice, 1900 f 23 and 29.4 f 3.2, 
respectively. 
1 /ADENOSlNE od+4) x 1 O3 
Fig.2. Double-reciprocal plot of ADA activity in 
erythrocytes vs adenosine concentration from control 
(0) and wsl/wsC (0) mice. Symbols represent means f 
SE of four separate experiments for control and three 
experiments for w.Wwst mice. Points lacking error bars 
indicate that the SE values did not exceed the size of the 
symbols. Regression lines were drawn according to 
weighted least-squares analyses. V,, (nmol/mg protein 
per 30 min) and K,,, (CtM) values were 64.3 f 1.4 and 
20.8 f 1.6 for controls, and 61.1 f 3.0 and 37.1 f 3.0 
for wst/wst mice, respectively. 
were calculated as total activity per organ since 
spleen and thymus weights were severely reduced 
and this was reflected by the 84 and 77% reduc- 
tion, respectively in the total ADA activity of these 
organs. V,,,,, values of ADA activity in spleens 
from wst/wst mice (fig.1) were significantly in- 
creased by 43% (P < O.Ol), and no significant dif- 
ferences were found in the Km values. For blood 
(fig.2), no differences in V,,, values were found, 
however the Km values from wst/wst mice were 
significantly (P < 0.01) higher by 78% (lower af- 
finity). 
4. DISCUSSION 
The reduced tissue weights in wst/wst mice 
necessitated the calculation of ADA activity both 
in terms of specific activity (per mg tissue and pro- 
tein), and total activity in the tissues. Based on 
specific activity measurements, significant in- 
creases in ADA activity were observed in whole 
brain, cerebellum, and spleen, and a significant 
decrease was found in thymus of wst/wst mice. 
However, based on total ADA activity, significant 
increases were noted in whole brain and 
cerebellum, whereas thymus and spleen activity 
were both dramatically reduced. The reduced 
weight and greater total ADA activity in brain 
tissues indicate an elevated absolute amount of en- 
zyme activity in these tissues. The functional 
significance of these changes in brain and 
peripheral tissues may become evident once the cell 
types within which they occur are determined. 
In agreement with the preliminary finding of 
Abbott et al. [4], the total ADA activity in thymus 
from w.st/wst mice was 17% of control levels. 
However, this reflects the large tissue deterioration 
which occurs in wst/wst mice since much smaller 
reductions were observed in the specific activity of 
ADA. Moreover, the specific activity and Vmax of 
ADA in spleen of wst/wst mice were significantly 
higher than controls despite a large loss of total ac- 
tivity. Previously, K,,, and I’,,,, values for ADA ac- 
tivity in erythrocytes from wst/wst mice were 
found to be 51 and 50% of control values, respec- 
tively [4]. In the present study, however, the K,,, 
value for erythrocytes from wst/wst mice, unlike 
the unchanged values in spleen, was almost twice 
that of controls and no changes in I’,,,,, were 
found. The differences in the results of the present 
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study and that of Abbott et al. [4] may have been 
due to different procedures used in measuring 
ADA activity, or more likely the cross-breeding of 
their wasted animals with ones carrying the visible- 
marker gene rugged. This intercrossing led to 
ragged-w&/ragged-wst mice which were almost 
completely naked and which, unlike the original 
wasted breeding mice supplied by Jackson 
Laboratories used here and by others [l-3], died 
before weaning. Thus, a genetic variance may have 
been introduced which accounts for the disparate 
results. 
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